Clinical Trials Browser

Phase 2 × Breast Neoplasms × bavituximab × Clear all

NCT00669591 2017-04-21

A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT02685306 2017-03-09

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00669565 2011-03-24

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

Phase 2 Completed

Breast Neoplasms